These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25748387)

  • 1. MicroRNAs-mediated cell fate in triple negative breast cancers.
    Sui X; Wang X; Han W; Li D; Xu Y; Lou F; Zhou J; Gu X; Zhu J; Zhang C; Pan H
    Cancer Lett; 2015 May; 361(1):8-12. PubMed ID: 25748387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of dysregulated microRNAs in triple-negative breast cancer (review).
    Yang F; Zhang W; Shen Y; Guan X
    Int J Oncol; 2015 Mar; 46(3):927-32. PubMed ID: 25571912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as regulatory elements in triple negative breast cancer.
    Gyparaki MT; Basdra EK; Papavassiliou AG
    Cancer Lett; 2014 Nov; 354(1):1-4. PubMed ID: 25107641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.
    Erturk E; Cecener G; Tezcan G; Egeli U; Tunca B; Gokgoz S; Tolunay S; Tasdelen I
    Gene; 2015 Feb; 556(2):163-9. PubMed ID: 25445393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer.
    Tang Q; Ouyang H; He D; Yu C; Tang G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2800-2809. PubMed ID: 31284781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer.
    Mathe A; Scott RJ; Avery-Kiejda KA
    Int J Mol Sci; 2015 Nov; 16(12):28347-76. PubMed ID: 26633365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
    PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets for triple-negative breast cancer.
    Herold CI; Anders CK
    Oncology (Williston Park); 2013 Sep; 27(9):846-54. PubMed ID: 24282978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-negative breast cancer survival in Iranian patients.
    Aghili M; Lashkari M; Farrokhpey AH; Izadi S
    Acta Med Iran; 2013 Sep; 51(8):560-6. PubMed ID: 24026994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells.
    Ren Y; Han X; Yu K; Sun S; Zhen L; Li Z; Wang S
    Mol Med Rep; 2014 Jul; 10(1):315-21. PubMed ID: 24821285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancer: An institutional analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
    Indian J Cancer; 2014; 51(2):163-6. PubMed ID: 25104201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancer.
    Zhang C; Han Y; Huang H; Min L; Qu L; Shou C
    Int J Oncol; 2014 Jun; 44(6):2025-33. PubMed ID: 24676531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Buschmann D; González R; Kirchner B; Mazzone C; Pfaffl MW; Schelling G; Steinlein O; Reithmair M
    Int J Oncol; 2018 Jun; 52(6):1765-1776. PubMed ID: 29620157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving therapy for triple-negative breast cancer.
    Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
    JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets.
    Gupta I; Rizeq B; Vranic S; Moustafa AA; Al Farsi H
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress of non-coding RNAs in triple-negative breast cancer.
    Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
    Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer.
    Alexandrova E; Lamberti J; Saggese P; Pecoraro G; Memoli D; Cappa VM; Ravo M; Iorio R; Tarallo R; Rizzo F; Collina F; Cantile M; Bonito MD; Botti G; Nassa G; Weisz A; Giurato G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.